A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/429 (2006.01) A61P 35/02 (2006.01)
Patent
CA 2761940
Provided herein are methods of administering N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7- (2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, or a pharmaceutically acceptable salt or solvate thereof, to human patients, including a specific patient population. Specifically, dosing, dosing schedules or dosing regimens are provided herein. Methods of treating proliferative diseases or FLT-3 mediated diseases in humans are also provided.
La présente invention concerne des procédés d'administration de N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7- (2-morpholin-4-yl-éthoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phényl}urée, ou son sel ou solvate pharmaceutiquement acceptable, à des patients humains, notamment une population de patients spécifique. Spécifiquement, l'invention concerne la posologie, les schémas posologiques ou les régimes posologiques. L'invention concerne également des méthodes de traitement de maladies prolifératives ou de maladies médiées par FLT-3 chez l'homme.
Corringham Robert E.
O'donnell Patrick B.
Ambit Biosciences Corporation
Osler Hoskin & Harcourt Llp
LandOfFree
Methods of treating proliferative diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating proliferative diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating proliferative diseases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1590304